Alicia Olivant Fisher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alicia Olivant Fisher has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad H. BaniHani
Alfred I. DuPont Hospital for Children
1 shared publication - Cecilia Kim
Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
1 shared publication - Deborah Stabley
Nemours Biomedical Research, Nemours /Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA
1 shared publication - Debra J. Abrams
The Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
1 shared publication - Hakon Hakonarson
The Center for Applied Genomics, Children’s Hospital of Philadelphia
1 shared publication - Jennifer A. Hagerty
Division of Pediatric Urology, Department of Surgery, Nemours Children's Health, Delaware. 1600 Rockland Rd., Wilmington, DE 19803, USA
1 shared publication
Latest Publications
- Open Access
- 21 October 2016
- Published by Springer Nature in BMC Urology
- Vol. 16 (1) , 1-8
Genomic copy number variation association study in Caucasian patients with nonsyndromic cryptorchidism
Copy number variation (CNV) is a potential contributing factor to many genetic diseases. Here we investigated the potential association of CNV with nonsyndromic cryptorchidism, the most common male congenital genitourinary defect, in a Caucasian population. Genome wide genotyping were performed in 559 cases and 1772 controls (Group 1) using Illumina HumanHap550 v1, HumanHap550 v3 or Human610-Quad platforms and in 353 cases and 1149 controls (Group 2) using the Illumina Human OmniExpress 12v1 or Human OmniExpress 12v1-1. Signal intensity data including log R ratio (LRR) and B allele frequency (BAF) for each single nucleotide polymorphism (SNP) were used for CNV detection using PennCNV software. After sample quality control, gene- and CNV-based association tests were performed using cleaned data from Group 1 (493 cases and 1586 controls) and Group 2 (307 cases and 1102 controls) using ParseCNV software. Meta-analysis was performed using gene-based test results as input to identify significant genes, and CNVs in or around significant genes were identified in CNV-based association test results. Called CNVs passing quality control and signal intensity visualization examination were considered for validation using TaqMan CNV assays and QuantStudio® 3D Digital PCR System. The meta-analysis identified 373 genome wide significant (p < 5X10−4) genes/loci including 49 genes/loci with deletions and 324 with duplications. Among them, 17 genes with deletion and 1 gene with duplication were identified in CNV-based association results in both Group 1 and Group 2. Only 2 genes (NUCB2 and UPF2) containing deletions passed CNV quality control in both groups and signal intensity visualization examination, but laboratory validation failed to verify these deletions. Our data do not support that structural variation is a major cause of nonsyndromic cryptorchidism.
- 21 October 2016
- Published by Springer Nature in BMC Urology
- Vol. 16 (1) , 1-8
Open AccessGenomic copy number variation association study in Caucasian patients with nonsyndromic cryptorchidism
Copy number variation (CNV) is a potential contributing factor to many genetic diseases. Here we investigated the potential association of CNV with nonsyndromic cryptorchidism, the most common male congenital genitourinary defect, in a Caucasian population. Genome wide genotyping were performed in 559 cases and 1772 controls (Group 1) using Illumina HumanHap550 v1, HumanHap550 v3 or Human610-Quad platforms and in 353 cases and 1149 controls (Group 2) using the Illumina Human OmniExpress 12v1 or Human OmniExpress 12v1-1. Signal intensity data including log R ratio (LRR) and B allele frequency (BAF) for each single nucleotide polymorphism (SNP) were used for CNV detection using PennCNV software. After sample quality control, gene- and CNV-based association tests were performed using cleaned data from Group 1 (493 cases and 1586 controls) and Group 2 (307 cases and 1102 controls) using ParseCNV software. Meta-analysis was performed using gene-based test results as input to identify significant genes, and CNVs in or around significant genes were identified in CNV-based association test results. Called CNVs passing quality control and signal intensity visualization examination were considered for validation using TaqMan CNV assays and QuantStudio® 3D Digital PCR System. The meta-analysis identified 373 genome wide significant (p < 5X10−4) genes/loci including 49 genes/loci with deletions and 324 with duplications. Among them, 17 genes with deletion and 1 gene with duplication were identified in CNV-based association results in both Group 1 and Group 2. Only 2 genes (NUCB2 and UPF2) containing deletions passed CNV quality control in both groups and signal intensity visualization examination, but laboratory validation failed to verify these deletions. Our data do not support that structural variation is a major cause of nonsyndromic cryptorchidism.